Company news

Arovella Therapeutics Limited news in 2021

Arovella Therapeutics Limited's news releases, calls and decks from 2021, newest first.

View company

AGM FY21 Presentation

December 15, 2021

Arovella licences novel monoclonal antibody from MD Anderson

December 12, 2021

Chile Ministry of Health Approval Granted for ZolpiMist

October 20, 2021

GM presentation

October 13, 2021

Dr Reuben Benjamin Appointed to SUDA iNKT Cell Therapy SAB

August 25, 2021

SUDA signs Licence and Distribution Agreement with STADA

August 24, 2021

ZolpiMist Update

August 23, 2021

iNKT cell therapy platform update

August 16, 2021

SUDA appoints new cell and gene therapy manufacturing expert

August 1, 2021

Disclosure Document Prospectus $3.65m

June 22, 2021

SUDA Placement Raises $3.65m

June 22, 2021

Investor Presentation incorporating iNKT Cell Platform

June 18, 2021

SUDA Licenses a Novel iNKT Cell Therapy Platform

June 18, 2021

Investor Presentation March 2021

March 29, 2021

Anagrelide Project Update

February 25, 2021

Appendix 4D & Interim Financial Half Year Report FY2021

February 25, 2021

Zelira Therapeutics Feasibility Study Update

February 15, 2021

Decks in 2021